Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,376 Results (Page 58 of 119)
- Relevance
  Sort by

Pleurodynia Treatment - Global Strategic Business Report

 Report
May 2026
270 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
69 Pages
Global

From

€3099EUR$3,500USD£2,678GBP

Transdermal Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
150 Pages
Global

From

€3321EUR$3,750USD£2,870GBP

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€3675EUR$4,150USD£3,176GBP

Breast Cancer Therapeutics Market 2024-2028

 Report
January 2024
168 Pages
Global

From

€2214EUR$2,500USD£1,913GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Eosinophilic Esophagitis - Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Stratergies and Forecast, 2020 - 2030

 Drug Pipelines
January 2022
84 Pages
Global

From

€8851EUR$9,995USD£7,648GBP

Lenalidomide Market by Type and by Application, by End-User, and By Region

 Report
March 2024
200 Pages
Global

From

€3675EUR$4,150USD£3,176GBP

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
February 2022
80 Pages
Global

From

€1771EUR$2,000USD£1,530GBP

High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Product, Manufacturer Type, Drug Type, Application, Region, and Segment Forecasts, 2026-2033

 Report
January 2026
150 Pages
Global

From

€5269EUR$5,950USD£4,553GBP

Glucagon-like Peptide 1 Market Report 2026

 Report
January 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Bacterial Vaccines Market - Global Strategic Business Report

 Report
May 2026
490 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Diuretics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

$Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image$

Refractory Multiple Myeloma- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2657EUR$3,000USD£2,296GBP

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
71 Pages
North America

From

€1328EUR$1,500USD£1,148GBP

Asia Pacific Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Asia Pacific

From

€1328EUR$1,500USD£1,148GBP

Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Europe

From

€1328EUR$1,500USD£1,148GBP

Company Snapshots: UK Pharmaceuticals

 Newsletter
May 2026
35 Pages
United Kingdom

From

€266EUR$300USD£230GBP

Company Snapshots: US Pharmaceuticals

 Newsletter
May 2026
35 Pages
United States

From

€266EUR$300USD£230GBP

Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€7040EUR$7,950USD£6,084GBP

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1771EUR$2,000USD£1,530GBP

2,376 Results (Page 58 of 119)
- 1
- 56
- 57
- 58
- 59
- 60

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.